Acute Pancreatitis

USMLE Step 1 trap: Prefers amylase over lipase as the diagnostic marker for acute pancreatitis. Serum lipase is more sensitive and specific for acute pancreatitis than amylase, which can be elevated in many other conditions.

Acute pancreatitis is autodigestion of the pancreas triggered by premature activation of pancreatic enzymes — most commonly by gallstones obstructing the ampulla or alcohol disrupting acinar cell physiology. It's one of the highest-yield GI topics on USMLE Step 1, and the exam hits it from every angle: etiology recognition, diagnostic criteria, management decisions, and complication timelines. The classic vignette is epigastric pain radiating to the back with elevated lipase, but the exam will make you work for the diagnosis by burying the key details in a longer clinical story.

The tricky parts fall into a few predictable traps. Students mix up amylase and lipase (lipase wins — it's more sensitive and specific). Students think NPO is always the right call (it's not — early enteral feeding is preferred in severe cases). And students flatten the complication timeline, calling any fluid collection a 'pseudocyst' regardless of timing. USMLE Step 1 loves testing these distinctions because they reflect actual clinical decision-making, not just memorized facts.

Beyond gallstones and alcohol, you need to know hypertriglyceridemia (>1000 mg/dL) as the third most common cause — it's a specific number the exam has tested. The mnemonic I GET SMASHED covers the full etiology list, but the exam will often embed the cause in a lab value or medication history rather than stating it outright. Know Cullen sign (periumbilical ecchymosis) and Grey-Turner sign (flank ecchymosis) as markers of retroperitoneal hemorrhage — both are late-presenting and indicate severe disease.

From real student decks

97%have cards covering this topic

86%have mature cards

1.0median lapses in 14 days

Well-covered in most decks — the challenge is retention, not exposure.

Common misconceptions

Common mistake

Wrong: Serum amylase is more specific and sensitive than lipase for diagnosing acute pancreatitis.

Right: Serum lipase is more sensitive and specific for acute pancreatitis than amylase, which can be elevated in many other conditions.

Amylase is elevated in many conditions unrelated to the pancreas — salivary gland disease, bowel ischemia, renal failure — which kills its specificity. Lipase is produced predominantly by the pancreas, making it both more sensitive and more specific for acute pancreatitis. On USMLE Step 1, if a question asks which lab to order to confirm pancreatitis, lipase is always the correct answer.

Common mistake

Wrong: Patients with acute pancreatitis must remain NPO until pain and lipase fully normalize.

Right: Early enteral feeding (within 24–48 hours) via nasojejunal tube is preferred in severe pancreatitis to maintain gut barrier and reduce infectious complications; prolonged NPO is harmful.

The old 'rest the pancreas' dogma has been replaced by evidence showing that gut barrier breakdown during prolonged fasting actually increases bacterial translocation and infectious complications. Early enteral nutrition — ideally via nasojejunal tube within 24–48 hours in severe pancreatitis — preserves the gut mucosa and reduces morbidity. TPN is a fallback only if enteral access isn't possible, and it carries its own risks.

Common mistake

Wrong: Pancreatic pseudocysts are an early complication appearing within the first few days of pancreatitis.

Right: Pseudocysts are a late complication developing 4+ weeks after acute pancreatitis; early fluid collections in the first week are acute peripancreatic fluid collections, not pseudocysts.

In the first week of acute pancreatitis, peripancreatic fluid collections are just that — acute fluid collections without a defined wall. A true pseudocyst requires at least 4 weeks to develop a fibrous, non-epithelialized wall. Calling a day-3 fluid collection a pseudocyst is a classic trap on exams; the correct term is acute peripancreatic fluid collection, and most of these resolve spontaneously.

Common mistake

Gap: Missing hypertriglyceridemia as a major cause of acute pancreatitis beyond gallstones and alcohol

Gallstones and alcohol account for ~80% of acute pancreatitis cases; hypertriglyceridemia (>1000 mg/dL) is the next most common cause and is often missed.

Gallstones (~40%) and alcohol (~30%) are the big two, but hypertriglyceridemia above 1000 mg/dL is the third most common cause and a specific threshold the exam tests. If you see a vignette with a patient who has poorly controlled diabetes, obesity, or is on certain medications (e.g., isotretinoin, estrogens) and develops pancreatitis, think hypertriglyceridemia first. Missing this means missing the diagnosis and the correct management approach.

Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →

Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

Given a clinical scenario or lab findings, identify the underlying cause of acute pancreatitis using the I GET SMASHED framework — including less obvious triggers like hypertriglyceridemia, hypercalcemia, or specific medications like thiazides and valproate.
Determine how acute pancreatitis is diagnosed: recognize that elevated serum lipase (≥3x upper limit of normal) plus characteristic pain is sufficient, and know when CT with contrast is indicated versus unnecessary.
Select the correct management priorities: aggressive IV fluid resuscitation (LR preferred over NS), early enteral nutrition in severe cases, and the specific indications for ERCP (cholangitis or persistent biliary obstruction) and antibiotics (infected necrosis only).
Distinguish early from late complications of acute pancreatitis — including SIRS, ARDS, and acute kidney injury in the first week versus pancreatic pseudocyst (≥4 weeks) and walled-off necrosis as late complications — and recognize the clinical features of each.

Can you avoid these mistakes?

A 45-year-old woman with poorly controlled type 2 diabetes presents with acute epigastric pain. Lipase is 850 U/L. A fasting lipid panel shows triglycerides of 1,400 mg/dL. What is the most likely etiology of her pancreatitis, and what serum value is the key trigger threshold?

You are managing a patient with severe acute pancreatitis (BISAP score 3). It is now 36 hours after admission. She is hemodynamically stable but still in pain. Should you keep her NPO and when, if ever, should you start feeding — and by what route?

On hospital day 2 of acute pancreatitis, CT shows a peripancreatic fluid collection adjacent to the pancreatic tail. Your intern calls it a pseudocyst. Are they correct? What is the right terminology, and when would this collection officially qualify as a pseudocyst?

A patient with acute gallstone pancreatitis is improving clinically with IV fluids, but develops fever, jaundice, and rigors on day 3. His bilirubin rises to 8 mg/dL. What complication has occurred, and does he now have an indication for ERCP?

Acute Pancreatitis

Common misconceptions

What the exam tests

Can you avoid these mistakes?

Related topics